Shaping of iNKT cell repertoire after unrelated cord blood transplantation. 2010

Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
AP-HP Hôpital Pitié-Salpêtière, INSERM UMR-S 945, Paris, France.

Invariant natural killer T (iNKT) cells have a pivotal role in immune regulation, tumor surveillance, and the induction of allograft tolerance. In this report, we analyze the recovery of iNKT cells after unrelated cord blood transplantation (UCBT) of adult patients with high-risk acute myeloid leukemia. We found that iNKT cells were reconstituted within 1 month after UCBT, at the same time as NK cells and before conventional T cells. These iNKT cells displayed a unique primed/central memory CD4(+)CD45RO(+)CCR7(+)CD62L(+) phenotype soon after the transplant. Interestingly, the functional competence of these cells was poor, except for their high GM-CSF production capacity. However, this post-graft functionally immature state was transient and all of the patients tested had fully functional iNKT cells 3 to 6 months post-UCBT and high cytolytic capacity for destroying primary CD1d(+) myeloid blast cells. Our results raise the possibility that iNKT cells might play a key role in graft-versus-leukemia activity after UCBT.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D055611 Natural Killer T-Cells A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN. Invariant Natural Killer T Cell,iNKT Cell,Invariant Natural Killer T-Cells,NKT Cell,NKT Cells,Natural Killer T-Cell,iNKT Cells,Cell, iNKT,Cells, iNKT,Invariant Natural Killer T Cells,Killer T-Cell, Natural,Killer T-Cells, Natural,Natural Killer T Cell,Natural Killer T Cells,T-Cell, Natural Killer,T-Cells, Natural Killer
D036101 Cord Blood Stem Cell Transplantation Transplantation of STEM CELLS collected from the fetal blood remaining in the UMBILICAL CORD and the PLACENTA after delivery. Included are the HEMATOPOIETIC STEM CELLS. Umbilical Cord Blood Stem Cell Transplantation,Blood Stem Cell Transplantation, Umbilical Cord,Placental Blood Stem Cell Transplantation,Stem Cell Transplantation, Cord Blood,Stem Cell Transplantation, Placental Blood

Related Publications

Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
September 2002, Annals of hematology,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
April 2003, Pediatric nephrology (Berlin, Germany),
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
January 2007, Cytotherapy,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
July 2008, Bone marrow transplantation,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
August 2012, Pediatric transplantation,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
November 2003, Bone marrow transplantation,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
April 2010, Bone marrow transplantation,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
March 2023, Annals of hematology,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
June 2003, Pediatrics international : official journal of the Japan Pediatric Society,
Vivien Beziat, and Stéphanie Nguyen, and Mark Exley, and Abla Achour, and Tabassonne Simon, and Patrice Chevallier, and Anne Sirvent, and Stéphane Vigouroux, and Patrice Debré, and Bernard Rio, and Vincent Vieillard, and
June 2017, Bone marrow transplantation,
Copied contents to your clipboard!